We prospectively evaluated the efficacy of hyaluronic acid (HA) as an adjuvant treatment to hasten the improvement of nasal respiration and to minimize patients' discomfort in the postoperative radiofrequency volumetric tissue reduction (RFVTR) of inferior turbinates.
T he inferior turbinate plays a major role in filtering, warming, and humidifying inspired air 1 and protecting the host with mucosal IgAs. 2 Inferior turbinate enlargement due to rhinitis is one of the main causes of chronic nasal obstruction. Chronic nasal obstruction is a common symptom of nasal disease and has many sequelae including mouth breathing, dryness of the oropharynx, nasal speech, disordered sleep, 3 restlessness, malaise, an adverse effect on quality of life, 4 and reduced lung volumes. 2 Rhinitis may be allergic, infective, vasomotor, hormonal, or secondary to medication. Some patients are refractory to medical management or show only slight response and complain of persistent symptoms. Alternatively, some patients prefer surgical treatment. In these instances many inferior turbinate surgical techniques may be offered. 5, 6 Turbinate surgery is common and has been reported as the eighth most common procedure performed by otolaryngologists. 2, 3 One of them is the radiofrequency technique. Radiofrequency reduction of the inferior turbinates has emerged as a new and possibly cost-effective local anesthetic treatment. 3 Through targeted and controlled dosing it creates a submucosal tissue shrinkage and contraction thus reducing turbinate volume. Because everything is happening submucosally, nothing should be changed with regard to the mucociliary transport system at the epithelial surface; one consequently maintains mucociliary function while achieving tissue volume reduction of the submucosa. 7, 8 After endonasal surgery, painless lavages of the nasal fossae are a very important element of postoperative nasal care and provide elimination of secretions, crusts, and debris. This procedure is necessary to achieve complete recovery. Several different solutions are usually used for nasal lavages: isotonic, hypertonic, or alkaline-buffered saline as well as ocean water have been used for nasal lavage. Among them, the isotonic saline solution is one of the most frequently used solutions. 9 Hyaluronic acid (HA) is a naturally occurring nonsulfated glycosaminoglycan with a high molecular weight of 4000-20,000,000 Da. HA structure consists of polyanionic disaccharide units of glucuronic acid and N-acetyl-glucosamine connected by alternating b1-3 and b1-4 bonds. It is a linear polysaccharide of the extracellular matrix of connective tissue, synovial fluid, embryonic mesenchyma, vitreous humor, skin, and many other organs and tissues of the body. The main functions of HA include tissue healing (including activation and moderation of the inflammatory responses), promotion of cell proliferation, migration, and angiogenesis. 10 It also promotes re-epithelization via proliferation of basal keratinocytes. HA is a hygroscopic macromolecule and its solutions are highly osmotic; it forms a scaffold to which several sulfur proteoglycans bind. Such structures can reach considerable size and are able to trap large quantities of water and ions, providing hydration and tissue turgescence. Some studies have shown that in the oral mucosa, this property enables the control of tissue hydration during periods of the inflammation process or response to tissue injury resulting in ulcer formation. The aim of this study was to investigate the potential effect of the use of HA as adjuvant treatment to hasten improvement in nasal respiration and to minimize patients' discomfort in the postoperative radiofrequency volumetric tissue reduction (RFVTR) of inferior turbinates.
MATERIALS AND METHODS
Eighty consecutive adult patients with nasal obstruction resulting from inferior turbinate hypertrophy refractory to medical therapy (1 month of topical corticosteroid) were prospectively enrolled from February to April 2012. Patients with previous turbinate surgery, significant septal deformity, septal perforation, ala collapse, nasal polyposis, benign or malignant tumors of the nasal cavity, and nasal radiotherapy were excluded, in addition to patients with diabetes mellitus, oral steroid use, coagulation disorders, cardiac pacemakers, and uncontrolled hypertension. All included patients, having undergone RFVTR, were randomized and divided into two groups:
dissolved in 2 mL of isotonic solution twice a day through Rinowash (Air Liquide Medical Systems S.p.A., Bovezzo, Italy) (a nebulizer designed to treat upper airway structures, creating micronized particles), B. The saline group (35 patients; 14 women and 21 men; mean age, 42 years; range, 18-75 years) received normal saline nasal irrigation twice a day.
The treatment in both groups was applied from the 1st postoperative day and continued for 14 days. Seven patients (five patients belonging to HA and two patients of the saline group) who had not come to postoperative controls were excluded from the study.
The study protocol was approved by the Research Ethics Committee at our institution and each patient signed a written informed consent.
Surgical Procedure
The radiofrequency energy was delivered by the somnoplasty (Somnus Medical Technologies, Inc., Bartlett, TN) and the SP 1100 turbinate handpiece (40-mm-long needle electrode consisting of a distal 15-mm active portion and a proximal 25-mm insulated part) with thermocouples within the electrode to allow the surgeon feedback during treatment: this included tissue temperature, power used, and total energy delivered. Before the treatment, a cotton pledget soaked with 2% mepivacaine and xylometazoline solution was introduced into each inferior meatus. The patient was placed in the supine position and after 10 minutes, under 0°and 30°endoscopic vision, the active 10-mm portion of the electrode and at least 2 mm of the insulation were inserted submucosally while the energy was delivered into three different sites of each turbinate (anterior, middle, and posterior portion). The energy delivered for each puncture was 300 J with an average duration of 59 Ϯ 16 seconds and a plateau tissue temperature of 75 Ϯ 5.6°C. After treatment, all of the patients in both groups were discharged without any limitation of normal daily activities and no nasal pack was needed.
Evaluation
The patients were asked to mark the severity of their symptoms on a standard 10-cm visual analogic scale (VAS) ranging from 0 (most comfortable) to 10 (the most severe symptoms, dissatisfying situations). The assessment of the subjective symptoms included nasal obstruction, sneezing, itchy nose, feeling of dryness, hyposmia, cacosmia, headache, nasal bleeding episodes, snoring, perioperative pain, and patient satisfaction.
Postoperative endoscopic nasal examination, in particular, turbinate edema, secretions, and crusts, was performed with 0°, 4-mm rigid endoscope by a surgeon not involved in the treatment of these patients. The findings of the examination were graded by a surgeon not involved in the treatment of these patients using a 3-point scale (0 ϭ none, 1 ϭ mild, 2 ϭ moderate, and 3 ϭ severe). Patients were instructed not to clean their nose and not to take medication at least 3 hours before endoscopic nasal examination. The assessment of crust formation was done by one observer. All patients were evaluated postoperatively at the 1st, 2 nd , and 4th week.
We also analyzed the cost, time, satisfaction, and compliance of both groups.
Statistical Analysis
A statistical analysis was performed using the Statistical Package for Social Sciences Software (SPSS for Windows; SPSS, Inc., Chicago, IL). Data are shown as mean and standard deviation. Parametric (Student's t-test) tests were used to compare different values. Our criterion for statistical significance was set at values of p Ͻ 0.05 (two tailed).
RESULTS
Fifty-seven included patients were analyzed in the study (Table 1) . No uncontrolled bleeding was observed during or after the operation; only two patients in saline group reported self-limited nasal bleeding in the first 3 postoperative weeks. No inflammation and/or allergic reactions were registered.
VAS Score
The mean VAS score of the HA group at the 1st week was significantly lower than control group (3.36 Ϯ 1.89 versus 6.95 Ϯ 1.52; p Ͻ 0.05). The VAS score remained significantly lower in the HA group also at the 2nd week (3.43 Ϯ 1.27 versus 5.75Ϯ1.39; p Ͻ 0.05), becoming similar to the control group at the 4th week (1.43 Ϯ 0.58 versus 1.66 Ϯ 0.63 Ϯ SD; p ϭ ns; Table 2 ).
Endoscopic Nasal Score
Since the first visit and during all of the 1st month, the HA group showed lower endoscopic nasal scores than the saline group (p Ͻ 0.05), especially for crusts, statistically significant in the first 2 weeks (Table 3 ).
Other Parameters
Both groups showed good patient satisfaction, but the compliance in the HA group was lower than that of the saline group (76% versus 98%), probably because of the longer average time of administration and higher cost of HA compared with saline solution; in particular, the mean full cost of the HA treatment is estimated at ϳ€50 for each patient (ϳ€3.6/die) and the mean time of administration is that of a few minutes. No adverse outcomes related to HA were recorded and irreversible sense of smell alterations were found in both groups. We also noticed that a traumatic cleaning of the nasal cavities by suction in the HA group compared with the saline group is associated with less pain and bleeding from crust detachments.
DISCUSSION
Today, HA is widely used in many branches of medicine, especially in esthetic medicine where it is used as a filling material for folds and creases as well as the enlargement of whole body parts (lips, breasts, ; contraindications or interactions with drugs are not reported. We found no description of the application of HA to relieve discomfort in postoperative RFVTR. The form of the drug that we used in our study was a mixture of saline solution and HA, a natural constituent of human tissues. Millions of successful injections performed around the world make it a product characterized by the high level of safety. HA, unlike other materials, exhibits better water absorption and was successfully used in atrophic rhinitis. This might be an additional advantage for patients suffering from nasal crusts and atrophic rhinitis because it contributes to better moisturization of the mucous membrane. 11 The goal of turbinate surgery is to obtain an improvement of nasal breathing with preservation of the physiological function of the turbinate while experiencing minimal discomfort or adverse effects. The safety and efficacy of radiofrequency turbinate surgery for hypertrophied turbinate in association with a decrease in operative morbidity and postoperative complications has been well demonstrated. Obtaining good nasal breathing in immediate postoperative time as showed in our sample study means that the patient can go back to normal daily activity a few days after surgery, with an enormous impact on social expense: indeed, the aforementioned cost is well below the cost of 2 weeks of HA treatment. The postoperative discomfort of patients evaluated by VAS score is determined not only by crusts but also by nasal mucosal edema and secretions typically abundant in the 1st weeks after RFVTR. Through Rinowash we have a good concentration of the HA solution at the head of turbinate (the terminal of Rinowash is close to the head of the inferior turbinate), where we typically have the maximal concentration of crusts in postoperative RFVTR; at the same time the nebulized particles can reach the body and the tail of the inferior turbinate favoring the healing of all the inferior turbinate. The Rinowash device also allows the HA solution to reach the osteomeatal complex, ameliorating sinus drainages compromised by postoperative nasal inflammation. 12 There is still a lack of data on the molecular processes involved in nasal mucosa wound healing after radiofrequency tissue ablation of the inferior nasal turbinate. It is known, however, that, especially during the 1st weeks, the fibrin crust formations overlying the epithelium and the overall re-epithelization start 7 days after wounding and are usually completed within 8-10 weeks 13 ; the patient, consequently, feels a fastidious nasal congestion especially in the 1st postoperative weeks The earlier healing time improved in the HA group compared with control nasal cavities reflects the capacity of HA to favorably influence effects on tissue repair [14] [15] [16] also minimizing crusts, edema, and the risk of infection (Fig 1) . The most significant clinical findings noted in HA patients compared with patients treated only with isotonic saline solution in the present study were prevention of crust formation, reduction of mucosal swelling, and nasal secretions, particularly in the first 2 postoperative weeks with minor discomfort of patients during medication in the follow-up visit; the HA group showed a faster onset of improvement in nasal respiration with a great impact on quality of life.
CONCLUSION
The results of this prospective study suggest a role of HA in RFVTR as a supportive treatment for a faster improvement of nasal respiration. It also minimizes patients' discomfort in the postoperative nasal surgery. 
